ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity
September 26, 2019The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of 14 lots of prescription ranitidine capsules distributed by Sandoz Inc. ... -
Maker Halts Distribution of Generic Zantac Due to Possible Carcinogen
September 20, 2019Novartis, the maker of a generic form of Zantac, said Wednesday it will stop selling the medicine after investigations suggested that generic and branded versions contain a known carcinogen. -
NDMA discovered in samples of ranitidine medicines
September 17, 2019The EMA and the FDA are investigating some ranitidine medicines after they were found to contain NDMA, a probable human carcinogen.
Pharma Sources Insight January 2025
